NLRP3 and chronic obstructive pulmonary disease: Previous research demonstrated that arginine administration improved pulmonary function in a rat model of chronic obstructive pulmonary disease (COPD) by regulating the ROS/NLRP3/NF-κB signaling pathway and reducing inflammatory mediator levels (43).